Biotech

All Articles

Praxis epilepsy drug lessens confiscations in period 2 trial

.Practice Precision Medicines has actually scored yet another midphase succeed in epilepsy this year...

Three execs surrender as Dyne articles blended information for DMD candidate

.After escaping a clinical hold several years back, Dyne Rehab has revealed brand new period 1/2 inf...

Arrowhead fires off period 3 records in unusual metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its hand ahead of a potential face-off along with Ionis, releas...

Pfizer, Valneva show lyme disease try effective for 2nd enhancer

.Pfizer as well as Valneva might have regarding 2 even more years to hang around prior to they help ...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion along with Ayla Ellison, Fierce Biotech Managing Editor as well as M...

New data show how Bayer's asundexian stopped working to stop strokes

.Bayer put on hold the stage 3 trial for its variable XIa inhibitor asundexian late in 2015 after th...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stockpile as fund presents intent to shape its development

.Galapagos is happening under added pressure coming from capitalists. Having constructed a 9.9% stak...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings...

Allist pays off Jacobio $21M, landing duty in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has acquired on its own a starring job in China's KRAS market, payi...